Industry News
What is proton therapy?
Nov 14, 2013
Proton therapy, also called Proton beam therapy, is the most advanced radiation therapy available today - it destroys cancer cells but does not attack surrounding healthy tissue nearly as much as traditional radiation therapy does. Proton therapy, a kind of particle therapy, directs proton beams with great precision at cancer cells. Read More
Anti-parasite drugs may treat cancer, immune diseases
Nov 13, 2013
US researchers have discovered that by modifying a long-standing drug used to treat serious parasitic diseases like malaria, they could get it to affect human proteins in a way that looks promising for the treatment of cancer and immune-related diseases.One of the researchers, Dr. Read More
Ferinject® reduces or delays requirement for alternative anaemia management compared with oral iron therapy
Nov 13, 2013
Results from the FIND-CKD study were presented at the American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia, USA. Read More
Purdue researchers apply new technique to manipulate virus, make it a possible cancer treatment
Nov 13, 2013
Purdue University researchers successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector... Read More
Ferinject® reduces or delays requirement for alternative anaemia management compared with oral iron therapy
Nov 13, 2013
Results from the FIND-CKD study were presented at the American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia, USA... Read More
Treatment of children with brain injury: Trial of New Vaccine for Recurrent Gliomas: 'Foreign Accent Syndrome'
Nov 13, 2013
Hospitals vary in management of children with traumatic brain injury - particularly in monitoring and preventing the harmful effects of increased intracranial pressure (ICP), according to a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health... Read More
News from the Annals of Family Medicine: November/December 2013
Nov 13, 2013
Patients Report High-Quality Care in Federally Supported Health Centers Patients seen in federally supported community health centers in the United States generally report high quality of care, according to data from a nationally representative survey of more than 4,500 patients... Read More
Discovery of key link responsible for colon cancer initiation and metastasis
Nov 13, 2013
Chronic inflammation has long been known as a key risk factor for cancer - particularly colon cancer - but the exact mechanisms of how inflammation heightens the immune response, and ultimately influences the initiation and progression of cancer have remained elusive. It is well established that anti-inflammatory drugs, like aspirin, reduce the risk of colorectal cancer... Read More
Low estrogen 'improves efficacy' of PARP inhibitors on womb cancer
Nov 13, 2013
Researchers have discovered that low hormone levels may make endometrial cancer tumors more sensitive to a class of medication called PARP inhibitors - drugs that induce cancer cell death. This is according to a study published in the journal Molecular Cancer Therapeutics. Endometrial cancer, also known as womb cancer, forms in the tissue lining of the uterus... Read More
News from Annals of Internal Medicine: 12 November 2013
Nov 13, 2013
1. Insufficient evidence that multivitamins prevent cancer, cardiovascular disease or death. A systematic review of published studies found insufficient evidence that vitamin and mineral supplements are effective for preventing cardiovascular disease (CVD), cancer, or mortality from those diseases in healthy adults, according to an article published in Annals of Internal Medicine... Read More
Previous Page Next Page